questionsmedicales.fr
Eucaryotes
Viridiplantae
Streptophyta
Embryophyta
Tracheobionta
Magnoliopsida
Boraginaceae
Boraginaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Disorders of Excessive Somnolence
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Boraginaceae : Questions médicales les plus fréquentes",
"headline": "Boraginaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Boraginaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Boraginaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Magnoliopsida",
"url": "https://questionsmedicales.fr/mesh/D019684",
"about": {
"@type": "MedicalCondition",
"name": "Magnoliopsida",
"code": {
"@type": "MedicalCode",
"code": "D019684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amsinckia",
"alternateName": "Amsinckia",
"url": "https://questionsmedicales.fr/mesh/D029682",
"about": {
"@type": "MedicalCondition",
"name": "Amsinckia",
"code": {
"@type": "MedicalCode",
"code": "D029682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.122"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Borago",
"alternateName": "Borago",
"url": "https://questionsmedicales.fr/mesh/D029683",
"about": {
"@type": "MedicalCondition",
"name": "Borago",
"code": {
"@type": "MedicalCode",
"code": "D029683",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.188"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Consoude",
"alternateName": "Comfrey",
"url": "https://questionsmedicales.fr/mesh/D020844",
"about": {
"@type": "MedicalCondition",
"name": "Consoude",
"code": {
"@type": "MedicalCode",
"code": "D020844",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.210"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cordia",
"alternateName": "Cordia",
"url": "https://questionsmedicales.fr/mesh/D031213",
"about": {
"@type": "MedicalCondition",
"name": "Cordia",
"code": {
"@type": "MedicalCode",
"code": "D031213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.327"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Echium",
"alternateName": "Echium",
"url": "https://questionsmedicales.fr/mesh/D036661",
"about": {
"@type": "MedicalCondition",
"name": "Echium",
"code": {
"@type": "MedicalCode",
"code": "D036661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Eriodictyon",
"alternateName": "Eriodictyon",
"url": "https://questionsmedicales.fr/mesh/D031322",
"about": {
"@type": "MedicalCondition",
"name": "Eriodictyon",
"code": {
"@type": "MedicalCode",
"code": "D031322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.415"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Heliotropium",
"alternateName": "Heliotropium",
"url": "https://questionsmedicales.fr/mesh/D028162",
"about": {
"@type": "MedicalCondition",
"name": "Heliotropium",
"code": {
"@type": "MedicalCode",
"code": "D028162",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.444"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lithospermum",
"alternateName": "Lithospermum",
"url": "https://questionsmedicales.fr/mesh/D029684",
"about": {
"@type": "MedicalCondition",
"name": "Lithospermum",
"code": {
"@type": "MedicalCode",
"code": "D029684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.501"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pulmonaria",
"alternateName": "Pulmonaria",
"url": "https://questionsmedicales.fr/mesh/D029685",
"about": {
"@type": "MedicalCondition",
"name": "Pulmonaria",
"code": {
"@type": "MedicalCode",
"code": "D029685",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Boraginaceae",
"alternateName": "Boraginaceae",
"code": {
"@type": "MedicalCode",
"code": "D028082",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maryam Noroozi",
"url": "https://questionsmedicales.fr/author/Maryam%20Noroozi",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, TN, 37996, USA."
}
},
{
"@type": "Person",
"name": "Farrokh Ghahremaninejad",
"url": "https://questionsmedicales.fr/author/Farrokh%20Ghahremaninejad",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran. fgh@khu.ac.ir."
}
},
{
"@type": "Person",
"name": "Mehrshid Riahi",
"url": "https://questionsmedicales.fr/author/Mehrshid%20Riahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran."
}
},
{
"@type": "Person",
"name": "James I Cohen",
"url": "https://questionsmedicales.fr/author/James%20I%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Botany and Plant Ecology, Weber State University, 1415 Edvalson St., Dept. 2504, Ogden, UT, 84408, USA."
}
},
{
"@type": "Person",
"name": "José Luis Guil-Guerrero",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Luis%20Guil-Guerrero",
"affiliation": {
"@type": "Organization",
"name": "Food Technology Division, University of Almería, 04120, Almería, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome.",
"datePublished": "2023-09-23",
"url": "https://questionsmedicales.fr/article/37748524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijcard.2023.131395"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37129416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00325481.2023.2203623"
}
},
{
"@type": "ScholarlyArticle",
"name": "Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/36070638",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpsychires.2022.08.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Major depressive episode with insomnia and excessive daytime sleepiness: A more homogeneous and severe subtype of depression.",
"datePublished": "2023-11-11",
"url": "https://questionsmedicales.fr/article/37979319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2023.115603"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study.",
"datePublished": "2023-10-09",
"url": "https://questionsmedicales.fr/article/37839271",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.sleep.2023.10.001"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Viridiplantae",
"item": "https://questionsmedicales.fr/mesh/D057948"
},
{
"@type": "ListItem",
"position": 4,
"name": "Streptophyta",
"item": "https://questionsmedicales.fr/mesh/D057949"
},
{
"@type": "ListItem",
"position": 5,
"name": "Embryophyta",
"item": "https://questionsmedicales.fr/mesh/D019669"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tracheobionta",
"item": "https://questionsmedicales.fr/mesh/D064028"
},
{
"@type": "ListItem",
"position": 7,
"name": "Magnoliopsida",
"item": "https://questionsmedicales.fr/mesh/D019684"
},
{
"@type": "ListItem",
"position": 8,
"name": "Boraginaceae",
"item": "https://questionsmedicales.fr/mesh/D028082"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Boraginaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Boraginaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Boraginaceae",
"description": "Comment identifier les plantes de la famille Boraginaceae ?\nQuels tests pour évaluer l'efficacité des Boraginaceae ?\nY a-t-il des critères spécifiques pour le diagnostic ?\nComment distinguer les Boraginaceae des autres familles ?\nQuels outils pour identifier les Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Boraginaceae",
"description": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?\nLes Boraginaceae provoquent-elles des effets indésirables ?\nQuels symptômes d'intoxication peuvent survenir ?\nComment reconnaître une réaction allergique aux Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Boraginaceae",
"description": "Comment éviter les effets indésirables des Boraginaceae ?\nQuelles précautions prendre avant d'utiliser des Boraginaceae ?\nLes Boraginaceae peuvent-elles interagir avec d'autres médicaments ?\nComment stocker les préparations à base de Boraginaceae ?\nY a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Boraginaceae",
"description": "Comment les Boraginaceae sont-elles utilisées en médecine ?\nQuels remèdes à base de Boraginaceae existent ?\nLes Boraginaceae sont-elles efficaces contre l'inflammation ?\nComment préparer un remède à base de Boraginaceae ?\nY a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Boraginaceae",
"description": "Quelles complications peuvent survenir avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des problèmes hépatiques ?\nComment gérer une réaction allergique aux Boraginaceae ?\nY a-t-il des risques d'intoxication avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Boraginaceae",
"description": "Qui est à risque d'allergies aux Boraginaceae ?\nLes femmes enceintes doivent-elles éviter les Boraginaceae ?\nQuels facteurs augmentent le risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les plantes de la famille Boraginaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des Boraginaceae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des critères spécifiques pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales."
}
},
{
"@type": "Question",
"name": "Comment distinguer les Boraginaceae des autres familles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des caractéristiques florales et des feuilles aide à la distinction."
}
},
{
"@type": "Question",
"name": "Quels outils pour identifier les Boraginaceae ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des guides botaniques et des applications de reconnaissance de plantes sont utiles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae provoquent-elles des effets indésirables ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines espèces peuvent causer des effets indésirables comme des nausées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'intoxication peuvent survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux Boraginaceae ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets indésirables des Boraginaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de commencer par de faibles doses et de surveiller les réactions."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant d'utiliser des Boraginaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier."
}
},
{
"@type": "Question",
"name": "Comment stocker les préparations à base de Boraginaceae ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés."
}
},
{
"@type": "Question",
"name": "Comment les Boraginaceae sont-elles utilisées en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés."
}
},
{
"@type": "Question",
"name": "Quels remèdes à base de Boraginaceae existent ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infusions, des pommades et des extraits sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae sont-elles efficaces contre l'inflammation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur."
}
},
{
"@type": "Question",
"name": "Comment préparer un remède à base de Boraginaceae ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Boraginaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines espèces contiennent des composés toxiques pouvant affecter le foie."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux Boraginaceae ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'intoxication avec les Boraginaceae ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation excessive peut entraîner des symptômes d'intoxication."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergies aux Boraginaceae ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les Boraginaceae ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation."
}
}
]
}
]
}
Sleep-related breathing disorders (SRBD) are related to cardiovascular outcomes in patients with chronic coronary syndrome (CCS). Whether SRBD-related symptoms are associated with prognostic biomarker...
Associations between frequency (never/rarely, sometimes, often, always) of self-reported SRBD-related symptoms (excessive daytime sleepiness [EDS]; morning tiredness [MT]; loud snoring; multiple awake...
EDS was associated (geometric mean ratio, 95% confidence interval) with increased levels of IL-6 (often 1.07 [1.03-1.10], always 1.15 [1.10-1.21]), GDF-15 (often 1.03 [1.01-1.06], always 1.07 [1.03-1....
In patients with CCS, stepwise increased frequency of SRBD-related symptoms, such as EDS and MT, were associated with gradually higher levels of IL-6 and GDF-15, each reflecting distinct pathophysiolo...
This real-world study aimed to characterize the impact of illness of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) who are adherent to continuous positive airway pr...
This cross-sectional study surveyed participants in Evidation Health's Achievement app (November 2020-January 2021), a mobile consumer platform that encourages users to develop healthy habits and prov...
In total, 476 participants (female,...
EDS influences choices related to physical activity, caffeine consumption, and diet in patients who are adherent with CPAP. More research is needed to understand the association between EDS and choice...
Given the high rate of depression associated with narcolepsy or obstructive sleep apnea (OSA), this analysis compared effects of solriamfetol treatment of excessive daytime sleepiness (EDS) in partici...
Previous studies have noted the crucial role of excessive daytime sleepiness (EDS) in the course of depressive illness, and more recently, a few studies documented its strong associations with an incr...
Excessive daytime sleepiness is common with obstructive sleep apnoea and can persist despite efforts to optimise primary airway therapy. The literature lacks recommendations regarding differential dia...
A panel of 10 international experts was convened to undertake a modified Delphi process. Statements were developed based on available evidence identified through a scoping literature review, and exper...
Consensus was achieved for 32 final statements. The panel agreed excessive daytime sleepiness is a patient-reported symptom. The importance of subjective/objective evaluation of excessive daytime slee...
Excessive daytime sleepiness in patients with obstructive sleep apnoea is a public health issue requiring increased awareness, recognition, and attention. Implementation of these statements may improv...
We aimed to explore excessive daytime sleepiness (EDS) and correlates of clinical characteristics by using cross-sectional and longitudinal analyses from the Parkinson's Progression Markers Initiative...
To evaluate the impact of solriamfetol, a dopamine and norepinephrine reuptake inhibitor, on on-the-road driving in participants with excessive daytime sleepiness (EDS) associated with obstructive sle...
Eligible participants were aged 21-75 years with OSA and EDS (Maintenance of Wakefulness Test mean sleep latency <30 minutes and Epworth Sleepiness Scale score ≥10). Participants were randomised 1:1 t...
Solriamfetol significantly reduced SDLP at 2 (n = 34; least squares mean difference, -1.1 cm; 95% CI, -1.85, -0.32; p = 0.006) and 6 hours postdose (n = 32; least squares mean difference, -0.8 cm; 95%...
Solriamfetol 300 mg/day significantly improved on-the-road driving performance in participants with EDS associated with OSA....
Daytime sleepiness is an important health problem. However, the dimensionality of the Epworth Sleepiness Scale (ESS) in older adults remains unclear. This study aimed to determine the prevalence of ES...
This is a community-based survey in which community-dwelling older adults aged ≥ 65 years participated. Excessive daytime sleepiness was assessed using the ESS and was defined as an ESS score of > 10....
In total, 3978 older adults participated in this study. The mean age was 76.6 ± 6.7 years, with 53.8% ≥ 75 years, and 57.1% were female. The prevalence of ESS-defined excessive daytime sleepiness was ...
The prevalence of ESS-defined excessive daytime sleepiness is high, and its correlates vary among older adults. This study also suggests a dual ESS structure in community-dwelling older adults....
Lower-sodium oxybate (LXB) is a novel formulation that is approved by the US Food and Drug Administration (FDA) to treat cataplexy and excessive daytime sleepiness (EDS) in adult patients and children...
This drug review discusses narcolepsy, current and upcoming pharmacotherapy, and LXB chemistry, pharmacodynamics, pharmacokinetics, and metabolism. Published results from LXB's phase 1 studies, a phas...
LXB is efficacious in treating daytime sleepiness and cataplexy in adults and children ≥7 years with narcolepsy. Using LXB instead of SXB formulations may benefit narcolepsy patients with cardiovascul...
People with epilepsy frequently encounter sleep disruptions that can stem from a variety of complex factors. Epilepsy-related sleep disturbance can lead to reduced quality of life and excessive daytim...
A cross-sectional study on 284 epilepsy patients was performed in a local tertiary centre. The demographic and clinical epilepsy data were collected. The Pittsburgh Sleep Quality Index (PSQI) and Epwo...
Poor sleep quality was reported in 78 (27.5%) patients while daytime hypersomnolence was present in 17 (6%) patients. The predictors of poor sleep quality include structural causes (OR = 2.749; 95% CI...
Sleep disturbances frequently coexist with epilepsy. Patients should be actively evaluated using the PSQI and ESS questionnaires. It is imperative to identify the key factors that lead to reduced slee...